Within cancer, tumor cell dedifferentiation is largely referred to as the epithelial to mesenchymal transition, where an upregulation in stem cell‐associated genes, such as NANOG, OCT‐4, and SOX‐2, induce a phenotype that is broadly known as a cancer stem cell (CSC).6, 48. The gene discussed is SOX2; the disease is cancer.